Skip to main content
Erschienen in: Infection 1/2017

09.11.2016 | Review

Association of HIV infection with extrapulmonary tuberculosis: a systematic review

verfasst von: Rupak Shivakoti, Davina Sharma, Gabeena Mamoon, Kiemanh Pham

Erschienen in: Infection | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

HIV/AIDS is a known risk factor for the development of pulmonary tuberculosis (PTB). However, the association is less clear between HIV and extrapulmonary tuberculosis (EPTB). We conducted a systematic review to determine the association between HIV and EPTB.

Methods

We searched the electronic databases Medline, Embase, and relevant conference literature using defined search terms for EPTB and HIV. Only publications in English and only studies reporting adjusted estimates were included, while our search criteria did not include restriction by age or geographic location of study participants. Qualitative and quantitative analyses (including I 2 test for heterogeneity) were performed.

Results

Sixteen studies (15 cross-sectional and 1 case–control) conducted from 1984 to 2016 were included in the final analyses after screening 5163 articles and conference abstracts. Our qualitative analysis showed heterogeneity in study design and study population characteristics along with a medium/high risk of bias in the majority of studies. While most of the individual studies showed increased odds of EPTB compared with PTB among HIV-infected individuals, we did not provide an overall pooled estimate, as the I 2 value was high at 93% for the cross-sectional studies.

Conclusions

While an association between HIV and EPTB is observed in most individual studies, the high heterogeneity and risk of bias in these studies highlight the need for further well-designed prospective cohort studies to assess the true risk of EPTB in the HIV-infected patient population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Adada H, Valley MA, Nour SA, Mehta J, Byrd RP Jr, Anderson JL, et al. Epidemiology of extra-pulmonary tuberculosis in the United States: high rates persist in the post-HIV era. Int J Tuberc Lung Dis. 2014;18:1516–21. doi:10.5588/ijtld.14.0319.CrossRefPubMed Adada H, Valley MA, Nour SA, Mehta J, Byrd RP Jr, Anderson JL, et al. Epidemiology of extra-pulmonary tuberculosis in the United States: high rates persist in the post-HIV era. Int J Tuberc Lung Dis. 2014;18:1516–21. doi:10.​5588/​ijtld.​14.​0319.CrossRefPubMed
6.
Zurück zum Zitat Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European union and European economic area 2002 to 2011. Euro Surveill 2013;18:1–9. Sandgren A, Hollo V, van der Werf MJ. Extrapulmonary tuberculosis in the European union and European economic area 2002 to 2011. Euro Surveill 2013;18:1–9.
7.
Zurück zum Zitat Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clin Inf Dis. 2009;49:1350–7. doi:10.1086/605559.CrossRef Peto HM, Pratt RH, Harrington TA, LoBue PA, Armstrong LR. Epidemiology of extrapulmonary tuberculosis in the United States, 1993–2006. Clin Inf Dis. 2009;49:1350–7. doi:10.​1086/​605559.CrossRef
11.
Zurück zum Zitat Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199–205. doi:10.1086/380644.CrossRefPubMed Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004;38:199–205. doi:10.​1086/​380644.CrossRefPubMed
13.
Zurück zum Zitat Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Int Med. 2006;144:427–37.CrossRefPubMed Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Int Med. 2006;144:427–37.CrossRefPubMed
14.
Zurück zum Zitat Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRefPubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.CrossRefPubMed
15.
Zurück zum Zitat von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7. doi:10.1016/S0140-6736(07)61602-X.CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7. doi:10.​1016/​S0140-6736(07)61602-X.CrossRef
20.
Zurück zum Zitat Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178–85.PubMed Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178–85.PubMed
21.
Zurück zum Zitat Kung HC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chen YC, Hung CC, Chang SC. Human immunodeficiency virus testing among patients with tuberculosis at a university hospital in Taiwan, 2000 to 2006. J Formos Med Assoc. 2009;108:108320327. doi:10.1016/S0929-6646(09),60072-3.CrossRef Kung HC, Sun HY, Chen MY, Hsieh SM, Sheng WH, Chen YC, Hung CC, Chang SC. Human immunodeficiency virus testing among patients with tuberculosis at a university hospital in Taiwan, 2000 to 2006. J Formos Med Assoc. 2009;108:108320327. doi:10.​1016/​S0929-6646(09),60072-3.CrossRef
22.
Zurück zum Zitat Namme LH, Marie-Solange D, Hugo Bertrand MN, Elvis T, Achu JH, Christopher K. Extrapulmonary tuberculosis and HIV coinfection in patients treated for tuberculosis at the Douala General Hospital in Cameroon. Ann Trop Med Publ Health. 2013;6:100–4.CrossRef Namme LH, Marie-Solange D, Hugo Bertrand MN, Elvis T, Achu JH, Christopher K. Extrapulmonary tuberculosis and HIV coinfection in patients treated for tuberculosis at the Douala General Hospital in Cameroon. Ann Trop Med Publ Health. 2013;6:100–4.CrossRef
23.
Zurück zum Zitat Prado TN, Caus AL, Marques M, Maciel EL, Golub JE, Miranda AE. Epidemiological profile of adult patients with tuberculosis and AIDS in the state of Espirito Santo, Brazil: cross-referencing tuberculosis and AIDS databases. J Bras Pneumol. 2011;37:93–9.CrossRefPubMedPubMedCentral Prado TN, Caus AL, Marques M, Maciel EL, Golub JE, Miranda AE. Epidemiological profile of adult patients with tuberculosis and AIDS in the state of Espirito Santo, Brazil: cross-referencing tuberculosis and AIDS databases. J Bras Pneumol. 2011;37:93–9.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Rieder HL, Cauthen GM, Bloch AB, Cole CH, Holtzman D, Snider DE Jr, et al. Tuberculosis and acquired immunodeficiency syndrome—Florida. Arch Int Med. 1989;149:1268–73.CrossRef Rieder HL, Cauthen GM, Bloch AB, Cole CH, Holtzman D, Snider DE Jr, et al. Tuberculosis and acquired immunodeficiency syndrome—Florida. Arch Int Med. 1989;149:1268–73.CrossRef
25.
Zurück zum Zitat Wilkinson D, Moore DA. HIV-related tuberculosis in South Africa–clinical features and outcome. S Afr Med J. 1996;86:64–7.PubMed Wilkinson D, Moore DA. HIV-related tuberculosis in South Africa–clinical features and outcome. S Afr Med J. 1996;86:64–7.PubMed
26.
Zurück zum Zitat Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015;15:544–51. doi:10.1016/S1473-3099(15)70058-7.CrossRefPubMed Bates M, Mudenda V, Shibemba A, Kaluwaji J, Tembo J, Kabwe M, et al. Burden of tuberculosis at post mortem in inpatients at a tertiary referral centre in sub-Saharan Africa: a prospective descriptive autopsy study. Lancet Infect Dis. 2015;15:544–51. doi:10.​1016/​S1473-3099(15)70058-7.CrossRefPubMed
27.
28.
Zurück zum Zitat Fortun J, Martin-Davila P, Gomez-Mampaso E, Gonzalez-Garcia A, Barbolla I, Gomez-Garcia I, et al. Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine. Int J Tuberc Lung Dis. 2014;18:478–85. doi:10.5588/ijtld.13.0555.CrossRefPubMed Fortun J, Martin-Davila P, Gomez-Mampaso E, Gonzalez-Garcia A, Barbolla I, Gomez-Garcia I, et al. Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine. Int J Tuberc Lung Dis. 2014;18:478–85. doi:10.​5588/​ijtld.​13.​0555.CrossRefPubMed
29.
Zurück zum Zitat Sama JN, Chida N, Polan RM, Nuzzo J, Page K, Shah M. High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study. Publ Health. 2016;138:101–7. doi:10.1016/j.puhe.2016.03.033. Sama JN, Chida N, Polan RM, Nuzzo J, Page K, Shah M. High proportion of extrapulmonary tuberculosis in a low prevalence setting: a retrospective cohort study. Publ Health. 2016;138:101–7. doi:10.​1016/​j.​puhe.​2016.​03.​033.
Metadaten
Titel
Association of HIV infection with extrapulmonary tuberculosis: a systematic review
verfasst von
Rupak Shivakoti
Davina Sharma
Gabeena Mamoon
Kiemanh Pham
Publikationsdatum
09.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 1/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0960-5

Weitere Artikel der Ausgabe 1/2017

Infection 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.